Other
No intervention performed
No intervention performed is an intervention with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completed
Determinant of Repeat Revascularization After Percutaneous Coronary Intervention
NCT05189249
completed
Clinical Impact of COVID-19 by P.1 SARS-CoV-2 Lineage
NCT04928469
completed
Central Blood Pressure Over 24 Hours (ABPM) and Left Ventricular Mass
NCT01278732
completed
Postoperative Hyperthyroidism
NCT01095341
Clinical Trials (4)
Showing 4 of 4 trials
NCT05189249
Determinant of Repeat Revascularization After Percutaneous Coronary Intervention
NCT04928469
Clinical Impact of COVID-19 by P.1 SARS-CoV-2 Lineage
NCT01278732
Central Blood Pressure Over 24 Hours (ABPM) and Left Ventricular Mass
NCT01095341
Postoperative Hyperthyroidism
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4